Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for March 2006
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Row over cardiovascular targets in new GP contract
Potentially life threatening condition ignored..(more)

 Schering backs merger with Bayer
Bid to create German super pharma company ..(more)

 Doctors oppose cuts to training budget
Quality of patient services under threat..(more)

 Investigation into UK medicines prices to continue
Fears new system will lack industry support..(more)

 Roche goes online to co-ordinate recruitment
Taleo's online system will improve global recruitment..(more)

 Fast growing recruiters thrive on clinical focus
Levy Associates ranked in recent Fast Track 100..(more)

 Protelos 'unique' among osteoporosis treatments
Drug should be used as first line treatment, say Servier..(more)

 Deal to speed UK uptake of new medicines revealed
Faster and wider access by end of 2006..(more)

 Pharma heading for collision course over cancer drug costs
NICE head and Pfizer exec disagree on funding..(more)

 Deaths reported in dementia trial
Investigators claim that results are no cause for concern..(more)

 World's biggest DNA project launched
UK Biobank aims to shed a new light on causes of disease..(more)

 Investigators to examine Northwick Park trial safety
Six volunteers admitted to intensive care unit..(more)

 New NHS ratings take tougher line on financial performance
Decreasing budget deficit could improve patient care..(more)

 Crestor hailed as first drug to reverse cardiovascular disease
First drug shown to unclog arteries ..(more)

 Schering to fight takeover bid from Merck KGaA
Bigger German pharma company would be created..(more)

 We're part of the solution, pharma tells Europe
EFPIA promotes industry as partner..(more)

 Bright future for NicOx after Pfizer glaucoma deal
Ophthamology deal boosts French biotech..(more)

 NHS chief executive resigns amid financial crisis
Crisp steps down as debts mount..(more)

 Herceptin challenges put patient safety at risk, says survey
NHS managers say patient safety at risk..(more)

 New Novartis blindness treatment filed in Europe
Lucentis up against Pfizer's Macugen..(more)

 ABPI chief calls for 'new rules of engagement'
Desire to radically renegotiate industry-NHS relationship..(more)

 Novartis files new Hepatitis B treatment in Europe
Telbivudine a potential new standard treatment ..(more)

 Bioenvision's leukaemia treatment gains positive opinion
Evoltra receives positive opinion from EMEA..(more)

 Erbitux closer to head and neck cancer approval
Merck's targeted cancer treatment nearer to EU approval..(more)

 GSK launches Europe's first rotavirus vaccine
Rotarix competing directly with Merck's Rotateq..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.